loading
前日終値:
$9.21
開ける:
$9.32
24時間の取引高:
12,677
Relative Volume:
0.03
時価総額:
$238.47M
収益:
-
当期純損益:
$-102.09M
株価収益率:
-8.4571
EPS:
-1.05
ネットキャッシュフロー:
$-108.72M
1週間 パフォーマンス:
-5.53%
1か月 パフォーマンス:
-4.41%
6か月 パフォーマンス:
+178.81%
1年 パフォーマンス:
+109.46%
1日の値動き範囲:
Value
$8.88
$9.35
1週間の範囲:
Value
$8.50
$9.69
52週間の値動き範囲:
Value
$2.2045
$12.78

Dbv Technologies Adr Stock (DBVT) Company Profile

Name
名前
Dbv Technologies Adr
Name
セクター
Healthcare (1174)
Name
電話
33(0)155427878
Name
住所
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Name
職員
106
Name
次回の収益日
2024-07-29
Name
最新のSEC提出書
Name
DBVT's Discussions on Twitter

DBVT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
DBVT
Dbv Technologies Adr
8.88 238.47M 0 -102.09M -108.72M -1.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-29 再開されました Goldman Sell
2023-01-04 アップグレード Societe Generale Hold → Buy
2022-12-16 ダウングレード Goldman Neutral → Sell
2022-05-10 ダウングレード Goldman Buy → Neutral
2021-09-14 アップグレード Societe Generale Hold → Buy
2021-01-22 ダウングレード Societe Generale Hold → Sell
2020-11-02 アップグレード Societe Generale Sell → Hold
2020-08-06 ダウングレード Societe Generale Buy → Sell
2020-08-05 繰り返されました H.C. Wainwright Buy
2020-03-17 ダウングレード Stifel Buy → Hold
2020-01-09 アップグレード Stifel Hold → Buy
2019-12-16 開始されました Citigroup Buy
2019-09-05 再開されました Morgan Stanley Equal-Weight
2019-06-17 開始されました Goldman Buy
2018-12-20 ダウングレード Barclays Overweight → Equal Weight
2018-12-20 ダウングレード BofA/Merrill Buy → Underperform
2018-12-20 ダウングレード Jefferies Buy → Hold
2018-12-20 ダウングレード Stifel Buy → Hold
2017-10-31 アップグレード Societe Generale Sell → Hold
2017-10-24 ダウングレード Societe Generale Buy → Sell
2017-10-23 ダウングレード Morgan Stanley Overweight → Equal-Weight
2017-06-23 開始されました Deutsche Bank Buy
2017-03-16 アップグレード Societe Generale Hold → Buy
2016-09-26 開始されました JMP Securities Mkt Outperform
2015-12-03 開始されました Barclays Overweight
2015-10-23 開始されました BofA/Merrill Buy
すべてを表示

Dbv Technologies Adr (DBVT) 最新ニュース

pulisher
Jun 16, 2025

European Stocks Shine As ADRs Climb Higher - Finimize

Jun 16, 2025
pulisher
Jun 14, 2025

DBV Technologies’ SWOT analysis: peanut allergy patch stock poised for growth - Investing.com

Jun 14, 2025
pulisher
Jun 14, 2025

DBV Technologies (NASDAQ:DBVT) Stock Price Crosses Above 50 Day Moving Average – Here’s Why - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

DBV Technologies to Participate in Upcoming EAACI Congress 2025 - The Manila Times

Jun 12, 2025
pulisher
Jun 11, 2025

DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

DBV Technologies Secures Full Shareholder Support at Annual Meeting: Key Governance Updates - Stock Titan

Jun 11, 2025
pulisher
Jun 03, 2025

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

DBV Technologies Reveals Special CEO Pay Package Ahead of Critical Shareholder Vote - Stock Titan

Jun 03, 2025
pulisher
Jun 03, 2025

European ADRs Climb With Biotech Stocks Leading The Charge - Finimize

Jun 03, 2025
pulisher
May 31, 2025

European ADRs Show Strength With Genfit And Novo Nordisk Leading Gains - Finimize

May 31, 2025
pulisher
May 30, 2025

DBV Technologies (NASDAQ:DBVT) Raised to Sell at The Goldman Sachs Group - Defense World

May 30, 2025
pulisher
May 29, 2025

Goldman Sachs cuts DBV Technologies stock to Sell, target EUR1.30 By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

Goldman Sachs cuts DBV Technologies stock to Sell, target EUR1.30 - Investing.com India

May 29, 2025
pulisher
May 29, 2025

Goldman Sachs reinstates DBV Technologies with sell rating, $7.25 target By Investing.com - Investing.com India

May 29, 2025
pulisher
May 29, 2025

Goldman Sachs reinstates DBV Technologies with sell rating, $7.25 target - Investing.com

May 29, 2025
pulisher
May 28, 2025

DBV Technologies (NASDAQ:DBVT) Price Target Raised to $21.00 at JMP Securities - Defense World

May 28, 2025
pulisher
May 27, 2025

European ADRs Rise On S&P Europe Select Index - Finimize

May 27, 2025
pulisher
May 26, 2025

DBV Technologies’ SWOT analysis: peanut allergy treatment stock faces pivotal trial - Investing.com

May 26, 2025
pulisher
May 22, 2025

European ADRs Show Optimism As Genfit Leads Gains - Finimize

May 22, 2025
pulisher
May 22, 2025

European ADRs Slip As US Index Notes Mixed Gains And Losses - Finimize

May 22, 2025
pulisher
May 18, 2025

Comparing DBV Technologies (NASDAQ:DBVT) and Maze Therapeutics (NASDAQ:MAZE) - Defense World

May 18, 2025
pulisher
May 16, 2025

Are You Looking for a Top Momentum Pick? Why DBV Technologies S.A. (DBVT) is a Great Choice - Nasdaq

May 16, 2025
pulisher
May 16, 2025

European ADRs Dip As Pharma And Tech Stocks See Mixed Results - Finimize

May 16, 2025
pulisher
May 15, 2025

Combined General Meeting of June 11, 2025 - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

DBV Technologies Sets Critical Shareholder Meeting: Key Documents Now Available - Stock Titan

May 15, 2025
pulisher
May 13, 2025

European ADRs Show Modest Gains With Standout Performers - Finimize

May 13, 2025
pulisher
May 11, 2025

StockNews.com Upgrades DBV Technologies (NASDAQ:DBVT) to “Hold” - Defense World

May 11, 2025
pulisher
May 09, 2025

FY2025 EPS Forecast for DBV Technologies Boosted by Analyst - Defense World

May 09, 2025
pulisher
May 07, 2025

European ADRs Dip With Mixed Performances Across Key Sectors - Finimize

May 07, 2025
pulisher
May 07, 2025

What is HC Wainwright’s Estimate for DBVT Q2 Earnings? - Defense World

May 07, 2025
pulisher
May 06, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DBV Technologies S.A.DBVT - Barchart.com

May 06, 2025
pulisher
May 06, 2025

HC Wainwright Issues Positive Forecast for DBV Technologies (NASDAQ:DBVT) Stock Price - Defense World

May 06, 2025
pulisher
May 05, 2025

DBV Technologies to Participate in the Citizens JMP Life Sciences Conference - The Manila Times

May 05, 2025
pulisher
May 05, 2025

DBV Technologies stock target raised to $16 by H.C. Wainwright - Investing.com Nigeria

May 05, 2025
pulisher
May 05, 2025

DBV Technologies CEO Set for Key Presentation: How to Watch Live Fireside Chat at JMP Conference - Stock Titan

May 05, 2025
pulisher
May 03, 2025

JMP Securities Boosts DBV Technologies (NASDAQ:DBVT) Price Target to $15.00 - Defense World

May 03, 2025
pulisher
May 01, 2025

DBV Technologies (NASDAQ:DBVT) Earns Hold Rating from Analysts at StockNews.com - Defense World

May 01, 2025

Dbv Technologies Adr (DBVT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Dbv Technologies Adr (DBVT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Mohideen Pharis
Chief Medical Officer
Jan 30 '25
Sale
0.85
600
510
110,510
Mohideen Pharis
Chief Medical Officer
Nov 25 '24
Sale
0.57
565
322
111,110
Mohideen Pharis
Chief Medical Officer
Nov 22 '24
Sale
0.53
342
181
111,675
Mohideen Pharis
Chief Medical Officer
Nov 21 '24
Sale
0.54
2,350
1,269
112,017
Mohideen Pharis
Chief Medical Officer
Jul 29 '24
Sale
0.98
1,785
1,749
79,367
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
大文字化:     |  ボリューム (24 時間):